13F-HR filed by ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 202 holding rows worth $538,666,337.
- Accession
- 0001940272-25-000003
- Filer
- CIK 1940272
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 202 entries on the cover page, a total value of $538,666,337 stated on the cover page (in dollars after the unit check, H1), rows summing to $538,666,337 with VALUE read as dollars as filed, 13F file number 028-23931. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 939,669 | $45,442,393 | dollars as filed | |
| EA SERIES TRUST | 02072L565 | ALPHA ARCH 1-3 | 337,125 | $37,586,066 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,483,404 | $35,147,546 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 940,858 | $34,002,608 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 968,866 | $16,557,920 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 390,729 | $15,703,399 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,486,461 | $15,147,038 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 2,210,019 | $13,812,619 | dollars as filed | |
| SPDR Bloomberg 1-3 Month T-Bill ETF | 78468R663 | SHS | 135,585 | $12,437,212 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 339,635 | $11,741,182 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 5,122,105 | $11,217,410 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 207,778 | $9,169,243 | dollars as filed | |
| ISHARES TR | 464287457 | COM | 103,337 | $8,549,070 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 523,767 | $8,050,299 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 122,921 | $7,844,818 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 750,000 | $7,725,000 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 301,134 | $7,374,772 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 5,970,768 | $7,284,337 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 264,900 | $7,152,300 | dollars as filed | call |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 1,879,114 | $6,558,108 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 48,044 | $6,337,964 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 177,136 | $6,263,529 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 1,678,063 | $6,108,149 | dollars as filed | |
| AA MISSION ACQUISITION CORP | G1000R101 | ORD SHS CL A | 578,359 | $6,032,284 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 742,495 | $5,902,835 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 804,220 | $5,846,679 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 50,000 | $5,574,000 | dollars as filed | put |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 5,625,000 | $5,484,375 | dollars as filed | principal |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 516,482 | $5,392,072 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 469,729 | $5,307,938 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,471,587 | $5,209,418 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 157,079 | $5,050,090 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 127,548 | $4,279,235 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 398,152 | $4,236,337 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 263,425 | $4,183,189 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 720,848 | $4,173,710 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 153,767 | $4,151,709 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 4,500,000 | $4,034,250 | dollars as filed | principal |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 104,853 | $3,917,308 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,360,291 | $3,768,006 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 100,774 | $3,669,181 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,461,234 | $3,667,697 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 971,100 | $3,651,336 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,801,184 | $3,613,527 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 50,000 | $3,572,500 | dollars as filed | put |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 641,690 | $3,426,625 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,116,047 | $3,236,536 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 216,166 | $3,108,467 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 71,143 | $2,879,869 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 66,960 | $2,818,346 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAH5 | NOTE 1.750% 3/0 | 2,666,627 | $2,741,292 | dollars as filed | principal |
| PTC THERAPEUTICS INC | 69366J200 | COM | 50,023 | $2,549,172 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 350,352 | $2,505,017 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 490,743 | $2,409,548 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 2,000,000 | $2,281,520 | dollars as filed | principal |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 170,000 | $2,204,900 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 313,354 | $2,199,745 | dollars as filed | |
| A SPAC III ACQUISITION CORP | G0544A103 | ORD SHS CL A | 215,000 | $2,162,900 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 36,890 | $1,954,063 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 100,000 | $1,929,000 | dollars as filed | call |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 149,385 | $1,901,671 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 53,125 | $1,781,812 | dollars as filed | |
| KALA BIO INC | 483119202 | COM NEW | 298,955 | $1,713,012 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 250,000 | $1,620,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 241,800 | $1,612,806 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,066,309 | $1,482,170 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 59,413 | $1,434,824 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 490,532 | $1,412,732 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 341,515 | $1,389,966 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 132,780 | $1,362,323 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 18,830 | $1,345,404 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 20,000 | $1,269,800 | dollars as filed | |
| Checkpoint Therapeutics Inc | 162828206 | Common Stock | 305,800 | $1,235,432 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 211,579 | $1,216,579 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 68,715 | $1,196,328 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 168,765 | $1,177,980 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 62,603 | $1,108,699 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 79,000 | $1,064,920 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 420,765 | $1,051,912 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 41,050 | $1,040,207 | dollars as filed | |
| ARES ACQUISITION CORP II | G33033104 | SHS CLASS A | 90,466 | $1,008,696 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 40,000 | $950,000 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 41,412 | $919,761 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 13,962 | $915,907 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 1,361 | $863,187 | dollars as filed | |
| KEEN VISION ACQUISITION CORP | G52443101 | UNIT 99/99/9999 | 75,000 | $841,500 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 27,900 | $817,470 | dollars as filed | |
| GRACE THERAPEUTICS INC | 00439U104 | COM | 343,512 | $783,207 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 147,404 | $719,332 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 56,300 | $717,262 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 15,000 | $661,950 | dollars as filed | call |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 35,619 | $616,565 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 4,500 | $615,780 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 101,096 | $603,543 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 4,250 | $600,992 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 50,000 | $595,500 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 170,448 | $591,455 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 194,665 | $585,942 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 801,277 | $576,919 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 22,641 | $544,290 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 122,690 | $522,659 | dollars as filed | |
| WISDOMTREE TR | 97717Y527 | FLOATNG RAT TREA | 10,000 | $503,300 | dollars as filed | |
| AGRICULTURE & NAT SOL ACQ CO | G0131Y100 | SHS CL A | 47,062 | $502,062 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 600 | $495,546 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,490 | $493,533 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 12,800 | $483,328 | dollars as filed | |
| RENOVORX INC | 75989R107 | COM NEW | 479,883 | $475,084 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 380,330 | $467,806 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 6,074 | $463,385 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 5,000 | $455,300 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 20,938 | $451,005 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 68,741 | $450,254 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 20,000 | $440,000 | dollars as filed | |
| NABORS ENERGY TRANSITION COR | G6363K106 | CL A | 39,900 | $436,905 | dollars as filed | |
| GERON CORP | 374163103 | COM | 266,176 | $423,220 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 24,328 | $422,334 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 35,743 | $412,474 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 17,000 | $371,790 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 600 | $355,119 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 100,000 | $347,000 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 700 | $346,689 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 4,900 | $346,381 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 18,285 | $331,690 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 27,925 | $327,002 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 8,000 | $326,440 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 281,600 | $323,840 | dollars as filed | |
| JVSPAC ACQUISITION CORP | G5212E105 | SHS CL A | 30,000 | $321,600 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 30,099 | $314,836 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 126,108 | $302,659 | dollars as filed | |
| NORDSTROM INC | 655664100 | COM | 12,000 | $293,400 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 10,000 | $273,700 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 42,800 | $268,356 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 14,600 | $264,990 | dollars as filed | |
| CN HEALTHY FOOD TECH GROUP C | 462837105 | COM | 25,000 | $262,000 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 75,545 | $255,342 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 21,200 | $251,856 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 227,228 | $249,951 | dollars as filed | |
| THERAPEUTICSMD INC | 88338N206 | COM NEW | 270,160 | $249,898 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 15,033 | $242,557 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 28,023 | $222,222 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,402 | $218,516 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 80,080 | $217,017 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 5,000 | $216,450 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 351,094 | $214,870 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 5,424 | $211,916 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 30,085 | $200,065 | dollars as filed | |
| COLOMBIERACQUISITIONCORPI | G2283U100 | COM SHS CL A | 18,513 | $197,163 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 142,958 | $190,134 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 13,873 | $188,603 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 23,100 | $186,648 | dollars as filed | |
| BIOMX INC | 09090D301 | COM | 299,598 | $166,487 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 25,000 | $165,000 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 146,183 | $160,801 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 10,000 | $148,900 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 119,320 | $145,570 | dollars as filed | |
| ANAVEX LIFE SCIENCES CORP | 032797300 | COM NEW | 16,221 | $139,176 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 20,000 | $134,600 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 34,479 | $127,572 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 403,716 | $117,118 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 43,173 | $115,272 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 70,419 | $111,262 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 101,008 | $110,099 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 23,799 | $106,620 | dollars as filed | |
| ALGONQUIN POWER & UTILITIES CO COM | 015857105 | Stock | 20,000 | $102,800 | dollars as filed | |
| CASI PHARMACEUTICALS INC COM NEW | G1933S101 | Stock | 47,420 | $102,427 | dollars as filed | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 28,300 | $101,597 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 244,966 | $97,986 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 102,156 | $97,058 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 15,000 | $91,800 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 10,000 | $80,100 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 87,799 | $79,897 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 15,000 | $79,350 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 10,000 | $75,000 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 533,200 | $67,343 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 10,100 | $63,327 | dollars as filed | call |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 76,757 | $61,782 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 120,012 | $57,642 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 41,346 | $56,644 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 16,600 | $56,274 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 18,643 | $52,573 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 15,700 | $52,281 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 67,754 | $46,073 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 10,000 | $43,000 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 115,867 | $36,139 | dollars as filed | |
| ILLUMINA INC COM | 62459M206 | COM | 19,146 | $35,037 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 111,000 | $33,866 | dollars as filed | |
| AA MISSION ACQUISITION CORP | G1000R127 | *W EXP 08/01/203 | 505,099 | $33,589 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 47,036 | $29,905 | dollars as filed | |
| A SPAC III ACQUISITION CORP | G0544A145 | RIGHT 01/02/2026 | 215,000 | $29,799 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 40,000 | $28,976 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 20,352 | $28,595 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 20,394 | $27,124 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 26,108 | $26,108 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 10,000 | $22,500 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F807 | COM | 40,228 | $12,684 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 13,400 | $8,770 | dollars as filed | |
| JVSPAC ACQUISITION CORP | G5212E113 | RIGHT 11/26/2026 | 30,000 | $8,400 | dollars as filed | |
| RTS/IRON HORSE ACQUISITIONS CORP EXP12/31/2099 | 462837121 | COM | 25,000 | $7,500 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 10,300 | $5,665 | dollars as filed | |
| 0 | G3034H141 | 0 | 13,144 | $2,366 | dollars as filed | |
| Cn Healthy Food Tech Group C W Exp 09/30/203 | 462837113 | SPAC Combination | 25,000 | $800 | dollars as filed | |
| Embrace Change Acquisition Corp | G3034H125 | Warrant | 18,000 | $695 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001940272-25-000003 | this filing | 2025-05-15 | acceptance time not in the bulk data set |